Anti-Proliferative and Pro-Apoptotic vLMW Fucoidan Formulas Decrease PD-L1 Surface Expression in EBV Latency III and DLBCL Tumoral B-Cells by Decreasing Actin Network.

导出 OA

翻译打印收藏纠错

第一作者： Jennifer,Saliba

第一单位： UMR CNRS 7276, INSERM 1262, CRIBL Laboratory, Faculty of Medecine, Limoges University, 87000 Limoges, France.

作者： Jennifer,Saliba ^[1] ; Chanez,Manseur ^[2] ; Hugo,Groult ^[2] ; Hussein,Akil ^[1] ; Mona,Tannoury ^[3] ; Danielle,Troutaud ^[1] ; Thierry,Maugard ^[2] ; Jean,Feuillard ^[1] ; Ingrid,Arnaudin ^[4] ; Chantal,Jayat-Vignoles ^[2]

作者单位： UMR CNRS 7276, INSERM 1262, CRIBL Laboratory, Faculty of Medecine, Limoges University, 87000 Limoges, France. ^[1] UMR CNRS 7266, LIENSs Laboratory, La Rochelle University, 17000 La Rochelle, France. ^[2] Faculty of Sciences II, Lebanese University, Beirut RGHC+4PR, Lebanon. ^[3] Hematology Laboratory, CHU Dupuytren, 2 Avenue Martin Luther King, CEDEX 87042 Limoges, France. ^[4]

关键词 DLBCLs EBV latency III B-cells PD-L1 actin network fucoidan very-low-molecular-weight fucoidan

主题词人类(Humans);疱疹病毒4型, 人(Herpesvirus 4, Human);爱泼斯坦巴尔病毒感染(Epstein-Barr Virus Infections);肌动蛋白类(Actins);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);多糖类(Polysaccharides)

DOI 10.3390/md21020132

PMID 36827173

发布时间 2023-03-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交